"From Technology to Treatment: What Can We Do To Expedite Progress?"

Stymied by treatments that range from mediocre to poor, the ADD/ADHD community finds itself in a ditch. How can it pull itself out? It might start with the question: where does medical progress come from? What is required to get treatments -- in this case, devices -- past the finish line? What hurdles need to be jumped? And what can patients and their families -- some of whom demand faster medical "translation" -- do to help bring this about? For more, hear neural engineer Marom Bikson, who teaches at City College and co-directs the New York Center for Biomedical Engineering. He's also the co-founder and CEO of Soterix Medical Inc., a maker of devices which activate -- through noninvasive means -- selected regions of the brain. Soterix stimulators are being tested in stroke recovery and fibromyalgia, But the technology itself has been tried for pain, depression, speech-language therapy, tinnitus, schizophrenia, Parkinson's, Alzheimer's, and age-related cognitive dimming. And -- coming soon, maybe -- ADHD. About Our Support Group: Since 1992, the Manhattan Adult Attention Deficit Disorder Support Group has offered walk-in, peer-run support sessions for adults with ADD and ADHD. In addition, it sponsors workshops led by experts in ADD/ADHD and other aspects of mental health.